BBI Newsletter, The

View more issues:

Articles in March, 1998 issue of BBI Newsletter, The

• Coagulase-negative staphylococcal infections
• EU eyes implications of BSE ban
• XML technology backed by Marquette Medical
• Expansion forces NexMed move
• Post-menopausal hormone delivery devices
• Emerging Israeli firms showcase variety of new medical devices
  by Jeffrey Berg
• Diversification push into new sectors drives U.S. Surgical's efforts
• Healthdyne/Respironics now a $375M deal; other mergers OK'd rumored
• Percutaneous port system launched
• Immunomedics ends Mallinckrodt deals
• Esaote buys Pie Medical for $73M
  by Tom Clark
• British group okays TUNA reimbursement
• Digital systems' role in ascendance in all modalities of imaging
  by Philip Drew
• HIMA expands memberships
• New FDA rule zeroes in on clinical conflict of interest
  by Don Long
• Datex-Ohmeda aims for no. 1 in two segments
  by Tom Clark
• ICN to invest $300 in Russia
• 'Milestone' patent for Somnus
• Single European market for pharmaceuticals
• Endocare trials will treat breast cancer
• Glaxo/SmitkLine merger to go to Brussels
  by Tom Clark
• USS to press suit against Ethicon
• Proposed FDA rule targets trial conflicts
• Commerce Department sets China mission
• Roche/Boehringer deal to require divestments
  by Tom Clark
• Cygnus raises $56.8M in two offerings
• German health insurance improves
• Health care information technology markets are dynamic, in transition
  by Arthur Gasch
• SmithKline, Glaxo talk $70 billion merger
• Dog blood substitute a step closer to human product
  by Don Long
• Chiron teams with Stanford Informatics
• Canadian women may receive $15M in implant settlement
• Intensivists focus on quality while wrestling with costs of critical care
  by Arthur Gasch
• Computerized hospital prescribing
• Shiloov boosted by $10.75M investment
• ADAC expands one line, but drops other ventures
  by Don Long